Evaluation the effect of oral capsule of Peganum harmalaseed on bone density in menopausal womenprone to osteoporosis
Phase 3
Recruiting
- Conditions
- osteoprosis.Osteopathies and chondropathiesM80-M94
- Registration Number
- IRCT2017091910222N12
- Lead Sponsor
- Vice chancellor for research of Shahrekord University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
Inclusion Criteria: Postmenopausal women who at least 12 month past after amenorrhea without correlation with pregnancy, breast-feeding or other hormonal disorders ;prone to osreoprosis with T score of less than 2.5 in bone density measurement.
Exclusion criteria: Gastrointestinal absorption disorder; Thyroid patients; Kidney and liver diseases
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method T score. Timepoint: 3 month after intervention. Method of measurement: Bondensitometry.
- Secondary Outcome Measures
Name Time Method